Description
Fate Therapeutics, Inc, is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat orphan diseases, including hematologic malignancies, lysosomal storage disorders and muscular dystrophies. Its approaches utilize pharmacologic modalities, including small molecules and therapeutic proteins, and biological mechanisms to enhance the therapeutic potential of adult stem cells.
Address
Suite 200, 3535 General Atomics Court
SAN DIEGO, CA 92121
United States
SAN DIEGO, CA 92121
United States
Website
www.fatetherapeutics.comKey stats and ratios
| Q2 (Jun '13) | 2012 | |
| Net profit margin | -1908.28% | -533.30% |
| Operating margin | -1472.07% | -519.85% |
| EBITD margin | - | -485.28% |
| Return on average assets | -352.05% | -150.45% |
| Return on average equity | - | - |
| Employees | 33 |
No comments:
Post a Comment